US 7264813
Therapeutic uses of Dunaliella powder
granted A61KA61K31/192A61K31/216
Quick answer
US patent 7264813 (Therapeutic uses of Dunaliella powder) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
- Grant date
- Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/192, A61K31/216, A61K31/426, A61K31/427